Antibiotic Resistance and Typhoid
- PMID: 30845331
- PMCID: PMC6405283
- DOI: 10.1093/cid/ciy1111
Antibiotic Resistance and Typhoid
Abstract
Multiple drug (antibiotic) resistance (MDR) has become a major threat to the treatment of typhoid and other infectious diseases. Since the 1970s, this threat has increased in Salmonella enterica serovar Typhi, driven in part by the emergence of successful genetic clades, such as haplotype H58, associated with the MDR phenotype. H58 S. Typhi can express multiple antibiotic resistance determinants while retaining the ability to efficiently transmit and persist within the human population. The recent identification of extensively drug resistant S. Typhi only highlights the dangers of ignoring this threat. Here we discuss the evolution of the S. Typhi MDR phenotype and consider options for management.
Keywords: S. Typhi; H58; MDR; multiple drug resistance; typhoid.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures

References
-
- O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. Review of antimicrobial resistance. London: HM Government and Wellcome trust; 2016.
-
- World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.
-
- Dougan G, Baker S. Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever. Annu Rev Microbiol 2014; 68:317–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical